Management of Common Emergency Department Diagnoses in the Philippines
Acute Coronary Syndrome (ACS)
Immediate Assessment and Triage
Perform a 12-lead ECG within 10 minutes of arrival to distinguish STEMI from non-ST-elevation ACS (NSTE-ACS), as this determines the entire treatment pathway. 1, 2
- Measure high-sensitivity cardiac troponin immediately at presentation (0 hours) with results available within 60 minutes, then repeat at 3-6 hours after symptom onset to identify rising or falling patterns 1, 3
- STEMI accounts for approximately 30% of ACS cases and is caused by complete coronary artery occlusion, while NSTE-ACS represents 70% and results from partial or intermittent occlusion 2
STEMI Management
Primary percutaneous coronary intervention (PCI) within 120 minutes of presentation reduces mortality from 9% to 7% and is the definitive treatment. 2
- If timely PCI cannot be achieved within 120 minutes (accounting for potential 60-minute delays due to system constraints), administer fibrinolytic therapy with alteplase, reteplase, or tenecteplase at full dose for patients younger than 75 years, or half dose for patients ≥75 years 1, 2
- For patients arriving by ambulance, transport directly to hospitals with 24/7 catheterization laboratory facilities 1
- If the dedicated cathlab is unavailable upon arrival, proceed with fibrinolysis rather than waiting 1
- Perform left ventriculography during catheterization to assess for mechanical complications 1
NSTE-ACS Risk Stratification and Management
Calculate the TIMI risk score (0-7 points based on: age ≥65 years, ≥3 CAD risk factors, prior coronary stenosis ≥50%, ST deviation, ≥2 anginal events in 24 hours, aspirin use in prior 7 days, elevated cardiac biomarkers) to guide invasive strategy timing. 1
Very high-risk patients (cardiogenic shock, recurrent refractory chest pain, acute heart failure, hemodynamic instability) should be managed identically to STEMI with immediate invasive strategy. 1
- High-risk patients (established NSTEMI with dynamic ST changes, LVEF <40%, or congestive heart failure) require early invasive coronary angiography within 24 hours 1
- Intermediate-risk patients (diabetes, renal dysfunction with eGFR <60 mL/min/1.73 m²) should receive medical stabilization and can be evaluated non-invasively with coronary CT angiography if available 1
- Low-risk patients should undergo conservative management with non-invasive stress testing 1
Immediate Medical Therapy
Start dual antiplatelet therapy immediately: aspirin 150-300 mg oral loading dose plus a P2Y12 inhibitor (ticagrelor or prasugrel). 3
- Administer sublingual nitroglycerin 0.3-0.4 mg every 5 minutes for up to 3 doses for ongoing ischemic pain 3
- Avoid clopidogrel and ticagrelor if lopinavir/ritonavir or other CYP3A4 inhibitors are being used (relevant in COVID-19 or HIV contexts) 1
Troponin Interpretation Pitfalls
Mild troponin elevations (<2-3 times upper limit of normal) in older patients with pre-existing cardiac disease do not require workup for type 1 MI unless accompanied by anginal chest pain or ECG changes. 1
- Marked elevations (>5 times upper limit of normal) warrant consideration of myocarditis, Takotsubo syndrome, spontaneous coronary dissection, or type 1 MI, and should prompt echocardiography if ECG is non-diagnostic 1
Acute Ischemic Stroke
Time-Critical Assessment
Treat stroke patients with the same urgency as acute myocardial infarction or severe trauma, regardless of deficit severity, as outcomes are time-dependent. 4
- Establish the exact time of symptom onset (when patient was last at baseline) as the single most critical piece of information, since this determines thrombolysis eligibility 4
- Perform immediate non-contrast head CT to differentiate ischemic stroke from intracerebral hemorrhage before any specific treatment 4
- Obtain 12-lead ECG, complete blood count, electrolytes, coagulation studies (aPTT, INR), renal function, glucose, and troponin without delay 4
Thrombolysis Protocol
Administer intravenous rt-PA (alteplase) for patients presenting within 3 hours of symptom onset who meet eligibility criteria, as this is highly effective in improving outcomes. 4
- Maintain blood pressure below 180/105 mmHg during and for at least 24 hours after thrombolysis to prevent hemorrhagic transformation 4
- Delay aspirin administration until 24 hours after thrombolysis 4
Antiplatelet Therapy for Non-Thrombolysis Candidates
Administer aspirin 160-300 mg/day within 48 hours of ischemic stroke onset for patients not receiving thrombolysis. 4
Transient Ischemic Attack (TIA) Management
Admit patients with high-risk TIA (ABCD2 score >4) to a stroke unit or evaluate within 24-48 hours, as stroke risk reaches 13% in the first 90 days. 4
- Low-risk TIA patients (ABCD2 score ≤4) can be managed as outpatients with evaluation within 7-10 days 4
- The ABCD2 score includes: Age ≥60 years (1 point), Blood pressure ≥140/90 mmHg (1 point), Clinical features of unilateral weakness (2 points) or speech disturbance without weakness (1 point), Duration ≥60 minutes (2 points) or 10-59 minutes (1 point), Diabetes (1 point) 4
Supportive Care
Monitor temperature and treat fever (>38°C) aggressively, as hyperthermia worsens neurological outcomes. 4
- Initiate early gradual mobilization 4
- Provide continuous cardiac monitoring for at least 24 hours to detect atrial fibrillation and other arrhythmias 4
- Reserve anticonvulsants only for documented seizures 4
Severe Asthma Exacerbation
Immediate Triage and Assessment
Measure FEV1 or peak expiratory flow (PEF) immediately to classify severity: severe exacerbations show FEV1 or PEF <40% predicted, moderate exacerbations 40-69% predicted. 1
- Assess for life-threatening features: inability to speak in full sentences, respiratory rate >30/min, heart rate >120/min, oxygen saturation <90%, silent chest, altered mental status, or paradoxical thoracoabdominal movement 1
Primary Treatment Protocol
Administer oxygen to maintain SpO2 ≥90%, inhaled short-acting beta-2 agonists (albuterol/salbutamol) via nebulizer or MDI with spacer every 20 minutes for the first hour, and systemic corticosteroids (prednisone 40-60 mg PO or methylprednisolone 40-80 mg IV) within the first hour. 1
- Continuous nebulized albuterol is appropriate for severe exacerbations 1
- Add ipratropium bromide (0.5 mg nebulized every 20 minutes for 3 doses, then as needed) for severe exacerbations 1
Reassessment and Disposition
Repeat FEV1 or PEF measurement after 1 hour of treatment to guide disposition: discharge if ≥70% predicted with minimal symptoms, admit if <50% predicted or incomplete response with risk factors for asthma-related death. 1
- Patients with FEV1 or PEF 50-69% predicted require individualized assessment considering risk factors; extended observation in a holding unit may be appropriate 1
Discharge Planning
Prescribe systemic corticosteroids for 3-10 days after discharge to reduce relapse risk. 1
- Consider intramuscular depot corticosteroid injection for patients at high risk of non-adherence 1
- Continue inhaled corticosteroids during systemic corticosteroid therapy 1
- Consider initiating inhaled corticosteroids at discharge for patients not already receiving them 1
- Provide written discharge plan with instructions for medication use, symptom monitoring, and when to seek care 1
- Schedule follow-up appointment before discharge to increase adherence 1
Acute Heart Failure
Immediate Severity Assessment
Classify patients as high-severity requiring immediate resuscitation bay or ICU/CCU transfer if they exhibit respiratory distress (respiratory rate >25/min, SpO2 <90% on supplemental oxygen, increased work of breathing) or hemodynamic instability (systolic BP <90 mmHg, severe arrhythmia, heart rate <40 or >130 bpm). 5
Simultaneous Monitoring and Treatment
Initiate continuous pulse oximetry, arterial blood pressure monitoring, respiratory rate assessment, and 12-lead ECG immediately upon arrival while beginning treatment. 5
- Monitor dyspnea, heart rhythm, urine output, and peripheral perfusion continuously 5
- Obtain cardiac troponin to exclude acute coronary syndrome as precipitant 5
- Measure BNP or NT-proBNP to confirm diagnosis and assess severity 5
Diuretic Therapy Protocol
Administer IV furosemide 40-80 mg bolus if diuretic-naïve, or at least equal to the patient's chronic oral daily dose if already on diuretics, within 60 minutes of presentation. 5
- Target urine output ≥100-150 mL/hour within 6 hours and urinary sodium ≥50-70 mmol/L within 2 hours 5
- Keep total furosemide dose <100 mg in first 6 hours and <240 mg in first 24 hours to avoid excessive diuresis and renal dysfunction 5
Treatment Goals
Maintain systolic blood pressure >90 mmHg with adequate peripheral perfusion, SpO2 >90%, and symptom improvement. 5
Disposition After Initial Stabilization
After approximately 2 hours of ED management, admit hemodynamically and respiratorily stable patients to general cardiology or internal medicine wards; transfer patients with persistent instability (need for intubation, cardiogenic shock, ongoing severe respiratory distress) to ICU/CCU; observe rapidly improving patients in ED observation unit for ≤24 hours. 5
- Schedule cardiology follow-up within 1-2 weeks for discharged patients 5
Dengue Fever with Warning Signs
Recognition of Warning Signs
Identify warning signs that predict progression to severe dengue: abdominal pain or tenderness, persistent vomiting, clinical fluid accumulation (ascites, pleural effusion), mucosal bleeding, lethargy or restlessness, liver enlargement >2 cm, or rising hematocrit with rapid platelet decline. [General Medicine Knowledge]
Fluid Management
Administer isotonic crystalloid solutions (normal saline or Ringer's lactate) at maintenance rates initially, increasing to 5-7 mL/kg/hour for 1-2 hours if warning signs develop, then reduce gradually based on clinical response. [General Medicine Knowledge]
- Monitor hematocrit every 4-6 hours during critical phase (days 3-7 of illness) [General Medicine Knowledge]
- Avoid excessive fluid administration, which can precipitate pulmonary edema and pleural effusion [General Medicine Knowledge]
Monitoring and Admission Criteria
Admit all patients with warning signs for close monitoring with serial hematocrit, platelet count, vital signs, and urine output assessment. [General Medicine Knowledge]
- Discharge only when: afebrile for 24 hours without antipyretics, improving clinical status, adequate oral intake, stable hematocrit, platelet count >50,000/μL and rising, and no respiratory distress [General Medicine Knowledge]
Sepsis
Early Recognition and Resuscitation
Initiate the "sepsis bundle" within 1 hour of recognition: obtain blood cultures before antibiotics, administer broad-spectrum antibiotics, measure lactate, and begin fluid resuscitation with 30 mL/kg crystalloid for hypotension or lactate ≥4 mmol/L. [General Medicine Knowledge]
Antibiotic Selection for Philippines Context
Choose empiric antibiotics based on suspected source: ceftriaxone 2 g IV plus metronidazole 500 mg IV for intra-abdominal sources; ceftriaxone 2 g IV for community-acquired pneumonia; piperacillin-tazobactam 4.5 g IV for healthcare-associated infections or immunocompromised patients. [General Medicine Knowledge]
- Consider local resistance patterns; carbapenem-resistant organisms are increasingly prevalent in Philippine hospitals [General Medicine Knowledge]
Hemodynamic Support
Administer norepinephrine as first-line vasopressor if mean arterial pressure remains <65 mmHg after initial fluid resuscitation. [General Medicine Knowledge]
- Target mean arterial pressure ≥65 mmHg and lactate clearance [General Medicine Knowledge]
Trauma
Primary Survey: CAB Approach
Prioritize "Circulation, Airway, Breathing" (CAB) assessment in trauma, as life-threatening hemorrhage is the leading cause of preventable trauma death. 6
Hemorrhage Control
Apply tourniquets immediately for life-threatening extremity hemorrhage, use direct wound packing for junctional and truncal bleeding, and implement permissive hypotension (target systolic BP 80-90 mmHg) until definitive hemorrhage control is achieved. 6
- Administer tranexamic acid 1 g IV over 10 minutes within 3 hours of injury, followed by 1 g IV over 8 hours 6
- Establish intraosseous vascular access if peripheral IV access fails 6
Transfusion Strategy
Implement balanced transfusion with 1:1:1 ratio of packed red blood cells, fresh frozen plasma, and platelets for patients requiring massive transfusion. 6
- Avoid over-resuscitation with crystalloids, which exacerbates coagulopathy 6
Airway Management
Assess airway patency immediately; common causes of airway compromise include head injury, alcohol intoxication, and decreased level of consciousness. 7
- Maintain cervical spine immobilization during airway management in trauma patients 7
Obstetric Emergencies: Eclampsia
Immediate Seizure Management
Administer magnesium sulfate 4-6 g IV loading dose over 15-20 minutes, followed by 1-2 g/hour continuous infusion, as this is superior to other anticonvulsants for eclamptic seizures. [General Medicine Knowledge]
- Monitor for magnesium toxicity: check deep tendon reflexes hourly, maintain urine output >25 mL/hour, and monitor respiratory rate [General Medicine Knowledge]
- Have calcium gluconate 1 g (10 mL of 10% solution) IV available as antidote for magnesium toxicity [General Medicine Knowledge]
Blood Pressure Control
Treat severe hypertension (systolic BP ≥160 mmHg or diastolic BP ≥110 mmHg) with IV labetalol 20 mg initial dose, doubling every 10 minutes (maximum 80 mg per dose) or IV hydralazine 5 mg, repeating every 20 minutes as needed. [General Medicine Knowledge]
- Target blood pressure <160/110 mmHg but avoid precipitous drops that compromise uteroplacental perfusion [General Medicine Knowledge]
Definitive Management
Arrange urgent delivery regardless of gestational age once maternal condition is stabilized, as delivery is the only definitive treatment for eclampsia. [General Medicine Knowledge]
- Continue magnesium sulfate for 24 hours postpartum to prevent recurrent seizures [General Medicine Knowledge]